058820 — CMG Pharmaceutical Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapNeutral

Market Cap
KR₩359bn
Enterprise Value
KR₩362bn
Revenue
KR₩99bn

Annual balance sheet for CMG Pharmaceutical Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	109,776	90,341	77,813	68,827	76,794
Net Total Accounts Receivable
Net Total Receivables	20,526	21,016	34,705	24,633	32,524
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	145,981	125,482	135,070	115,737	134,859
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	29,741	30,516	37,472	50,711	77,977
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	195,356	199,175	213,260	242,098	303,437
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	13,649	13,729	21,903	24,529	74,645
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Funded Status
Total Liabilities	14,225	14,472	28,307	51,866	113,895
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
ESOP Debt Guarantee
Unrealized Gain / Loss
Total Equity	181,131	184,702	184,953	190,233	189,542
Total Liabilities & Shareholders' Equity	195,356	199,175	213,260	242,098	303,437
Total Common Shares Outstanding